NCT06688721 Does Eco-driving Assistance (EDA) Have an Impact on Bus Driver's Health and Well-being?
| NCT ID | NCT06688721 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-02-10 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-02-10 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pragamatic trial is to assess the impact of eco-driving assistance (EDA) system on professional bus drivers' health and well-being. The main questions it aims to answer are: * Does the eco-driving assistance (EDA) act as a stressor for bus drivers ? * Does the physiological and psychological perceived stress increase when bus drivers are driving bus equipped with eco-driving assistance (EDA) ? An additional question consists in assessing the association between stress measurements and biomarkers in biological samples. Researchers will compare the heart rate variability (HRV) and perceived stress level when participant are allocated to EDA-equipped buses and non-EDA-equipped buses Participants will: * Drive buses equipped with eco-driving assistance (EDA) * Drive buses without eco-driving assistance (EDA) * Wear a wearable electrocardiogram (ECG) device (Bittium Faros) to record the heart rate variability (HRV) * Answer a questionnaire at the end of each working day (end-of-service questionnaire) * When allocated to bus with eco-driving assistance (EDA), read the EDA-generated report and answer some related questions in the end-of-service questionnaire * Upon acceptance only, a collection of biological samples and physiological measurement will be performed
Eligibility Criteria
Inclusion Criteria: * adult active bus driver * having signed the informed consent * having worked for at least one year as TPF bus driver * working at least 30 hours a week * no planned extended absences in the next 6 months (civil service, military service, long- term leave, retirement) Exclusion Criteria: * wearing a medical active implant (pacemaker, cardiac defibrillator, neurostimulator, other electronic implant) * known allergy or skin sensitivity to plasters
Contact & Investigator
Irina Guseva Canu, Professor
PRINCIPAL INVESTIGATOR
Unisanté
Frequently Asked Questions
Who can join the NCT06688721 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06688721 currently recruiting?
Yes, NCT06688721 is actively recruiting participants. Contact the research team at irina.guseva-canu@unisante.ch for enrollment information.
Where is the NCT06688721 trial being conducted?
This trial is being conducted at Givisiez, Switzerland.
Who is sponsoring the NCT06688721 clinical trial?
NCT06688721 is sponsored by Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland. The principal investigator is Irina Guseva Canu, Professor at Unisanté. The trial plans to enroll 50 participants.